Clinical Trial: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Plaque Psoriasis
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-blinded, Placebo-controlled, Multicenter Phase 2 Study Evaluating the Efficacy and Safety of TLL018 in Participants With Moderate-to-severe Plaque Psoriasis
Brief Summary:
This is a Phase 2, multicenter, randomized, double-blinded, parallel dose group, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of 3 doses of TLL018 as therapy in 120 participants with moderate-to-severe PP.
Read more